Welcome to LookChem.com Sign In|Join Free
  • or
AZEPAN-1-YL-ACETIC ACID, also known as azepane acetic acid, is a chemical compound with the formula C9H19NO2. It is a derivative of azepane, a saturated heterocyclic compound containing seven carbon atoms and one nitrogen atom in the ring. AZEPAN-1-YL-ACETIC ACID is recognized for its utility in pharmaceutical and organic synthesis applications due to its unique structure and properties, which make it a valuable building block in the development of various medications and other chemical compounds. However, it is crucial to handle AZEPAN-1-YL-ACETIC ACID with care to mitigate potential health and safety risks associated with its use.

52703-80-7

Post Buying Request

52703-80-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52703-80-7 Usage

Uses

Used in Pharmaceutical Industry:
AZEPAN-1-YL-ACETIC ACID is used as a pharmaceutical intermediate for its role in the synthesis of various medications. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of pharmaceutical chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, AZEPAN-1-YL-ACETIC ACID is utilized as a building block for the production of other chemical compounds. Its versatility in chemical reactions makes it an essential component in creating a wide range of organic molecules for different applications.

Check Digit Verification of cas no

The CAS Registry Mumber 52703-80-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,7,0 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 52703-80:
(7*5)+(6*2)+(5*7)+(4*0)+(3*3)+(2*8)+(1*0)=107
107 % 10 = 7
So 52703-80-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO2/c10-8(11)7-9-5-3-1-2-4-6-9/h1-7H2,(H,10,11)

52703-80-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail

  • Aldrich

  • (CBR00324)  Azepan-1-ylacetic acid  AldrichCPR

  • 52703-80-7

  • CBR00324-1G

  • 1,930.50CNY

  • Detail

52703-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(azepan-1-yl)acetic acid

1.2 Other means of identification

Product number -
Other names azepan-1-ylacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52703-80-7 SDS

52703-80-7Downstream Products

52703-80-7Relevant academic research and scientific papers

Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-((S)-3-(Cyclopent-1-en-1-yl)-1-((R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propenamide)

Johnson, Henry W.B.,Lowe, Eric,Anderl, Janet L.,Fan, Andrea,Muchamuel, Tony,Bowers, Simeon,Moebius, David C.,Kirk, Christopher,McMinn, Dustin L.

, p. 11127 - 11143 (2019/01/04)

Selective immunoproteasome inhibition is a promising approach for treating autoimmune disorders, but optimal proteolytic active site subunit inhibition profiles remain unknown. We reveal here our design of peptide epoxyketone-based selective low molecular mass polypeptide-7 (LMP7) and multicatalytic endopeptidase complex subunit-1 (MECL-1) subunit inhibitors. Utilizing these and our previously disclosed low molecular mass polypeptide-2 (LMP2) inhibitor, we demonstrate a requirement of dual LMP7/LMP2 or LMP7/MECL-1 subunit inhibition profiles for potent cytokine expression inhibition and in vivo efficacy in an inflammatory disease model. These and additional findings toward optimized solubility led the design and selection of KZR-616 disclosed here and presently in clinical trials for treatment of rheumatic disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 52703-80-7